Draw/line
Home / Compare / Tirzepatide vs Retatrutide

Tirzepatide vs Retatrutide

Tirzepatide is approved and widely prescribed. Retatrutide, often called Reta, is still experimental. Here is how they differ and why the trial numbers cannot be compared directly.

Side-by-side facts · No recommendation · Reviewed

TirzepatideRetatrutideSame for both

TirzepatideRetatrutide
Acts onGIP and GLP-1 receptorsGIP, GLP-1 and glucagon receptors
StatusFDA-approved (Mounjaro, Zepbound)Investigational, not approved anywhere
Legitimate supplyPrescriptionNone outside clinical trials
EvidenceLarge published trials, including a head-to-head trialPhase 3 results announced in 2026, not yet peer-reviewed
Expected FDA filingApprovedPlanned for early 2027

Why the numbers are not comparable

There has been no head-to-head trial. Retatrutide's phase 3 trials reported average weight loss of up to 22.6% at 80 weeks in one trial. Tirzepatide reported 20.2% at 72 weeks in SURMOUNT-5. Different trials enroll different people, run for different lengths of time and measure in different ways, so the figures cannot be set side by side as if they came from one study.

Retatrutide's full results have not yet been published in a peer-reviewed journal, and FDA has not reviewed them.

Side effects

Both cause mainly stomach and bowel side effects. In retatrutide trials, 13.5% of people on the highest dose stopped because of side effects, compared with 4.8% on placebo. Trials also recorded altered skin sensation.

Availability

Tirzepatide is available on prescription. Retatrutide is not legitimately available to patients anywhere. Anything sold online as retatrutide comes from outside the approved supply chain, with no assurance of identity, strength or sterility.

Questions

Is retatrutide better than tirzepatide?

No head-to-head trial exists, and retatrutide's results are not yet peer-reviewed or reviewed by FDA, so that cannot be answered yet.

When will retatrutide be approved?

The manufacturer plans to file for FDA approval in the first quarter of 2027. Approval is not guaranteed and review usually takes about a year.

Is retatrutide sold online real?

There is no approved product. Products sold online have no assurance of identity, strength or sterility.

Which compound, if any, suits a person is a decision for them and a licensed prescriber. This page compares published facts and does not recommend either.

Sources: ACC: SURMOUNT-5 journal scan; Eli Lilly: SURMOUNT-5 detailed results; Managed Healthcare Executive: GLP-1 pills; Prime Therapeutics: GLP-1 pipeline update, August 2026; Polsinelli: FDA compounded GLP-1 policy; Eli Lilly: TRIUMPH-2 and TRIUMPH-3 results; HCPLive: retatrutide phase 3 endpoints.

For research and educational use. Not medical advice. Regulatory status changes, so confirm the current position with FDA or a licensed professional.